Literature DB >> 9891040

Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog.

K Takeyama1, Y Masuhiro, H Fuse, H Endoh, A Murayama, S Kitanaka, M Suzawa, J Yanagisawa, S Kato.   

Abstract

The nuclear vitamin D receptor (VDR) is a member of a nuclear receptor superfamily and acts as a ligand-dependent transcription factor. A family of cotranscriptional activators (SRC-1, TIF2, and AIB-1) interacts with and activates the transactivation function of nuclear receptors in a ligand-dependent way. We examined interaction of VDR with these coactivators that was induced by several vitamin D analogs, since they exert differential subsets of the biological action of vitamin D through unknown mechanisms. Unlike other vitamin D analogs tested, OCT (22-oxa-1alpha,25-dihydroxyvitamin D3) induced interaction of VDR with TIF2 but not with SRC-1 or AIB-1. Consistent with these interactions, only TIF2 was able to potentiate the transactivation function of VDR bound to OCT. Thus, the present findings suggest that the structure of VDR is altered in a vitamin D analog-specific way, resulting in selective interactions of VDR with coactivators. Such selective interaction of coactivators with VDR may specify the array of biological actions of a vitamin D analog like OCT, possibly through activating a particular set of target gene promoters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9891040      PMCID: PMC116035          DOI: 10.1128/MCB.19.2.1049

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues.

Authors:  E Murayama; K Miyamoto; N Kubodera; T Mori; I Matsunaga
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

Review 2.  Molecular biology of the vitamin D hormone.

Authors:  M R Haussler; D J Mangelsdorf; B S Komm; C M Terpening; K Yamaoka; E A Allegretto; A R Baker; J Shine; D P McDonnell; M Hughes
Journal:  Recent Prog Horm Res       Date:  1988

3.  Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism.

Authors:  T Okano; N Tsugawa; S Masuda; A Takeuchi; T Kobayashi; Y Takita; Y Nishii
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

4.  26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3.

Authors:  Y Tanaka; H F DeLuca; Y Kobayashi; N Ikekawa
Journal:  Arch Biochem Biophys       Date:  1984-02-15       Impact factor: 4.013

5.  The effect of active vitamin D3 analogs and dexamethasone on the expression of osteocalcin gene in rat tibiae in vivo.

Authors:  T Ikeda; H Kohno; T Yamamuro; R Kasai; S Ohta; H Okumura; J Konishi; H Kikuchi; C Shigeno
Journal:  Biochem Biophys Res Commun       Date:  1992-12-15       Impact factor: 3.575

6.  25-hydroxy-26, 26,26,27,27,27-hexafluorovitamin D3: biological activity in the rat.

Authors:  Y Tanaka; D N Pahuja; J K Wichmann; H F De Luca; Y Kobayashi; T Taguchi; N Ikekawa
Journal:  Arch Biochem Biophys       Date:  1982-10-01       Impact factor: 4.013

7.  A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.

Authors:  J Abe; T Nakano; Y Nishii; T Matsumoto; E Ogata; K Ikeda
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

8.  Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.

Authors:  J Abe; Y Moriya; M Saito; Y Sugawara; T Suda; Y Nishii
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability.

Authors:  H L Henry; A W Norman
Journal:  Science       Date:  1978-09-01       Impact factor: 47.728

10.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  19 in total

1.  Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Authors:  Yasuo Kusunoki; Isao Matsui; Takayuki Hamano; Akihiro Shimomura; Daisuke Mori; Sayoko Yonemoto; Yoshitsugu Takabatake; Yoshiharu Tsubakihara; René St-Arnaud; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

2.  A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.

Authors:  M Watanabe; J Yanagisawa; H Kitagawa; K Takeyama ; S Ogawa; Y Arao; M Suzawa; Y Kobayashi; T Yano; H Yoshikawa; Y Masuhiro; S Kato
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

3.  Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching.

Authors:  Akiko Murayama; Mi-sun Kim; Junn Yanagisawa; Ken-ichi Takeyama; Shigeaki Kato
Journal:  EMBO J       Date:  2004-04-07       Impact factor: 11.598

4.  Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.

Authors:  Hirochika Kitagawa; Junn Yanagisawa; Hiroaki Fuse; Satoko Ogawa; Yoshiko Yogiashi; Atsuro Okuno; Hiromichi Nagasawa; Toshihiro Nakajima; Toshio Matsumoto; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha.

Authors:  H Endoh; K Maruyama; Y Masuhiro; Y Kobayashi; M Goto; H Tai; J Yanagisawa; D Metzger; S Hashimoto; S Kato
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 6.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

7.  The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes.

Authors:  Lee A Zella; Mark B Meyer; Robert D Nerenz; J Wesley Pike
Journal:  Endocrinology       Date:  2009-05-07       Impact factor: 4.736

Review 8.  Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.

Authors:  Diego Brancaccio; Jürgen Bommer; Daniel Coyne
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.

Authors:  Dennis Andress
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Drosophila TRAP230/240 are essential coactivators for Atonal in retinal neurogenesis.

Authors:  Janghoo Lim; Ok-Kyung Lee; Ya-Chieh Hsu; Amit Singh; Kwang-Wook Choi
Journal:  Dev Biol       Date:  2007-05-26       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.